Sherpa Venture Capital is a Beijing based venture capital firm investing in pharmaceutical and biotechnology companies. The firm focuses on pharmaceuticals, GeneTech, MedTech, drug discovery/delivery, laboratory services, medical services, and logistics. As of December 2019, the firm has made 12 investments with ten portfolio companies. Its portfolio companies include Immunochina, Yosemite Clinic, Hongyun Biology, Joinhealth Technology, Singleron Biotechnologies, Hui-Gene Therapeutics, and EpimAb Biotherapeutics.
Timeline
People
Name
Role
LinkedIn
Xing Chen
Director
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Is a
Company attributes
Industry
Venture capitalLocation
BeijingCompany status
Active
Crunchbase
Pitchbook
Venture Capital Firm attributes
Invested in
